Strategic Targeting for Optimal Prevention of Cancer
ConditionEarly Detection of Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorClinLogic LLC
About this trial
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Eligibility criteria
Qualifiers
individuals, ages 65 years or older;
must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
study subject has or had cancer
Disqualifiers
Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
study subject is unable to provide an accurate history due to mental incapacity
study subject is currently abusing illicit and/or prescription drugs;
Trial design
Treatments tested in this trial
- Genetic Testing
Treatment groups
No treatment groups listed
Sponsors and collaborators
ClinLogic LLC
Lead sponsor
MDGlobal
Collaborator
Source ClinicalTrials.gov